NO985205D0 - Krystallinsk (-)-3R,4R-trans-7-metoksy-2,2-dimetyl-3-fenyl-4-{4-[2-(pyrrolidin-1-yl)etoksyl]fenyl}kroman-hydrogenfumarat - Google Patents

Krystallinsk (-)-3R,4R-trans-7-metoksy-2,2-dimetyl-3-fenyl-4-{4-[2-(pyrrolidin-1-yl)etoksyl]fenyl}kroman-hydrogenfumarat

Info

Publication number
NO985205D0
NO985205D0 NO985205A NO985205A NO985205D0 NO 985205 D0 NO985205 D0 NO 985205D0 NO 985205 A NO985205 A NO 985205A NO 985205 A NO985205 A NO 985205A NO 985205 D0 NO985205 D0 NO 985205D0
Authority
NO
Norway
Prior art keywords
phenyl
trans
methoxy
dimethyl
pyrrolidin
Prior art date
Application number
NO985205A
Other languages
English (en)
Norwegian (no)
Other versions
NO985205L (no
Inventor
Svend Treppendahl
Klaus Snej Jensen
Scott E Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO985205L publication Critical patent/NO985205L/no
Publication of NO985205D0 publication Critical patent/NO985205D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO985205A 1996-05-08 1998-11-06 Krystallinsk (-)-3R,4R-trans-7-metoksy-2,2-dimetyl-3-fenyl-4-{4-[2-(pyrrolidin-1-yl)etoksyl]fenyl}kroman-hydrogenfumarat NO985205D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK55296 1996-05-08
PCT/DK1997/000211 WO1997042184A1 (en) 1996-05-08 1997-05-07 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen fumarate

Publications (2)

Publication Number Publication Date
NO985205L NO985205L (no) 1998-11-06
NO985205D0 true NO985205D0 (no) 1998-11-06

Family

ID=8094838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985205A NO985205D0 (no) 1996-05-08 1998-11-06 Krystallinsk (-)-3R,4R-trans-7-metoksy-2,2-dimetyl-3-fenyl-4-{4-[2-(pyrrolidin-1-yl)etoksyl]fenyl}kroman-hydrogenfumarat

Country Status (17)

Country Link
EP (1) EP0912543B1 (de)
JP (1) JP2951410B2 (de)
KR (1) KR20000010644A (de)
CN (1) CN1218462A (de)
AT (1) ATE262516T1 (de)
AU (1) AU710334B2 (de)
BR (1) BR9709060A (de)
CA (1) CA2253284A1 (de)
CZ (1) CZ359898A3 (de)
DE (1) DE69728271D1 (de)
HU (1) HUP9901738A3 (de)
IL (1) IL126345A (de)
NO (1) NO985205D0 (de)
PL (1) PL329624A1 (de)
RU (1) RU2182149C2 (de)
WO (1) WO1997042184A1 (de)
ZA (1) ZA973961B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104166678B (zh) * 2014-07-09 2018-04-10 苏州市职业大学 一种面向汉语微博的多种潜在属性整体挖掘系统及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
GB9301611D0 (en) * 1993-08-04 1993-08-04 Parisella Gerald Dexterity game
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
ATE262516T1 (de) 2004-04-15
BR9709060A (pt) 1999-08-03
NO985205L (no) 1998-11-06
JPH11501953A (ja) 1999-02-16
IL126345A0 (en) 1999-05-09
AU710334B2 (en) 1999-09-16
KR20000010644A (ko) 2000-02-25
AU2763897A (en) 1997-11-26
CZ359898A3 (cs) 1999-05-12
CN1218462A (zh) 1999-06-02
PL329624A1 (en) 1999-03-29
DE69728271D1 (en) 2004-04-29
HUP9901738A3 (en) 2000-12-28
JP2951410B2 (ja) 1999-09-20
HUP9901738A2 (en) 2000-07-28
CA2253284A1 (en) 1997-11-13
RU2182149C2 (ru) 2002-05-10
EP0912543B1 (de) 2004-03-24
WO1997042184A1 (en) 1997-11-13
EP0912543A1 (de) 1999-05-06
IL126345A (en) 2001-07-24
ZA973961B (en) 1997-12-04

Similar Documents

Publication Publication Date Title
BG101833A (bg) Гуаниново производно
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
AU3366297A (en) Polymorphic compounds
AU1120599A (en) New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
AU5242000A (en) Nematicidal trifluorobutenes
BG102474A (en) (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate
SI0775704T1 (en) Crystalline hydrochloride of (R)-(-)-2-(N-(4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-butyl)-aminomethyl)-chroman
AU2426595A (en) Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
AU3631197A (en) N-benzylpiperidine and tetrahydropyridine derivatives
GR3036305T3 (en) Chiral methyl phenyl oxazolidinones
BR0012751A (pt) Benzofuranos serotonérgicos
IN187760B (de)
NO985205D0 (no) Krystallinsk (-)-3R,4R-trans-7-metoksy-2,2-dimetyl-3-fenyl-4-{4-[2-(pyrrolidin-1-yl)etoksyl]fenyl}kroman-hydrogenfumarat
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
ZA200005110B (en) Process for preparing intermediates.
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
UA66859C2 (uk) Спосіб стереохімічно контрольованого одержання ізомерно чистих високозаміщених азациклічних сполук
AU2000246281A1 (en) Piperidine compounds and process for providing such
AU5618699A (en) N-substituted azabicycloheptane derivatives, production and use thereof
HUP9702005A1 (hu) Morfológiailag homogén bimoclomol, eljárás a tiszta polimorf módosulatok előállítására és hatóanyagként polimorf módosulatot tartalmazó gyógyászati készítmények
AU2002217529A1 (en) Process for preparing optically active 2,3-dihydro- benzofuran compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application